These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11868778)

  • 41. HEP DART 2005 -- frontiers in drug development for viral hepatitis.
    Feitelson MA
    IDrugs; 2006 Mar; 9(3):165-7. PubMed ID: 16523376
    [No Abstract]   [Full Text] [Related]  

  • 42. [Primary and secondary prevention of HBV-related hepatocellular carcinoma by antiviral treatment].
    Hosaka T
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():559-64. PubMed ID: 26845997
    [No Abstract]   [Full Text] [Related]  

  • 43. Prevention of primary liver cancer by immunization.
    Zuckerman AJ
    N Engl J Med; 1997 Jun; 336(26):1906-7. PubMed ID: 9197221
    [No Abstract]   [Full Text] [Related]  

  • 44. Update of research and management of hepatitis B.
    Okanoue T; Minami M
    J Gastroenterol; 2006 Feb; 41(2):107-18. PubMed ID: 16568369
    [No Abstract]   [Full Text] [Related]  

  • 45. USPSTF advises HBV screening for US groups at high risk of infection.
    Mitka M
    JAMA; 2014 Mar; 311(10):1004. PubMed ID: 24618947
    [No Abstract]   [Full Text] [Related]  

  • 46. [Chronic hepatitis B].
    Thimme R; Spangenberg HC; Blum HE
    Dtsch Med Wochenschr; 2008 Jan; 133(4):135-8. PubMed ID: 18197589
    [No Abstract]   [Full Text] [Related]  

  • 47. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Viral Infection and Tumors: Hepatitis B Virus Infection and Hepatocellular Carcinoma].
    Yokosuka O; Nakamoto S; Kanda T
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1861-5. PubMed ID: 30160885
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatitis B virus and the prevention of primary hepatocellular carcinoma.
    Blumberg BS; London WT
    N Engl J Med; 1981 Mar; 304(13):782-4. PubMed ID: 6258074
    [No Abstract]   [Full Text] [Related]  

  • 49. Management of patients with decompensated HBV cirrhosis.
    Fontana RJ
    Semin Liver Dis; 2003 Feb; 23(1):89-100. PubMed ID: 12616454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis B virus in hepatocarcinogenesis.
    Feitelson MA
    J Cell Physiol; 1999 Nov; 181(2):188-202. PubMed ID: 10497299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of hepatitis B therapy on the long-term outcome of liver disease.
    Liaw YF
    Liver Int; 2011 Jan; 31 Suppl 1():117-21. PubMed ID: 21205148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatocellular carcinoma at the cutting edge of science and practice.
    Pellicano R; El-Serag HB; Rizzetto M
    Minerva Med; 2010 Dec; 101(6):391-3. PubMed ID: 21196898
    [No Abstract]   [Full Text] [Related]  

  • 53. Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
    Davídsdóttir L; Duberg AS; Törner A; Aleman S; Bäck E; Ekdahl K; Blaxhult A; Ekbom A; Hultcrantz R
    Scand J Gastroenterol; 2010 Aug; 45(7-8):944-52. PubMed ID: 20384529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.
    Hung CH; Lu SN; Wang JH; Hu TH; Chen CH; Huang CM; Lee CM
    Antivir Ther; 2011; 16(7):959-68. PubMed ID: 22024511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
    Calvaruso V; Craxì A
    Liver Int; 2014 Feb; 34 Suppl 1():85-90. PubMed ID: 24373083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. We have a cancer vaccine--why don't we use it?
    Hall A
    Trop Med Int Health; 1998 May; 3(5):337-8. PubMed ID: 9623937
    [No Abstract]   [Full Text] [Related]  

  • 57. 'Yes, now you are free from chronic HCV infection, but . . .'.
    Toyoda H; Kumada T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):9-10. PubMed ID: 16706803
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ratio analysis of HBV-related liver disease and primary liver carcinoma development over 10 years in patients who received no antiviral therapy versus those treated with antiviral therapy].
    Huo H; Ren S; Wang S; Xu Y; Ma L; Liu Y; Jin Y; Zheng Y; Chen X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):68-70. PubMed ID: 24754089
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis B Virus Infection, MicroRNAs and Liver Disease.
    Sarkar N; Chakravarty R
    Int J Mol Sci; 2015 Aug; 16(8):17746-62. PubMed ID: 26247932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocellular carcinoma and hepatitis B surface protein.
    Li YW; Yang FC; Lu HQ; Zhang JS
    World J Gastroenterol; 2016 Feb; 22(6):1943-52. PubMed ID: 26877602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.